Crossmark

The combination of next generation sequencing and technological devices allows a precision medicine approach in congenital hyperinsulinism: the case of a pregnant mother and the child she gave birth

Crossref DOI link: https://doi.org/10.1007/s00592-024-02395-x

Published Online: 2024-10-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Valenzano, Marina https://orcid.org/0000-0003-3484-4626
Peduto, Antonella

Comba, Anna

Menzaghi, Claudia

Trischitta, Vincenzo
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 27 August 2024

Accepted: 13 October 2024

First Online: 23 October 2024

Declarations

:

: The Authors declare they have no financial interests.

: All procedures involving humans in this study were performed in accordance with the local hospital ethical standards and with the 1964 Helsinki Declaration and its later amendments.

: Informed consent was obtained from the patient.

: The participant has consented to the submission of the case report to the journal.

Document is current

Any future updates will be listed below